Latest Regulatory Framework News

Nine Entertainment reported a resilient FY25 with strategic transformation gains, digital subscription growth, and a major capital return following the sale of its Domain stake. Leadership changes and regulatory challenges frame its path forward.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

Encounter Resources has completed the first tranche of its $25 million share placement, raising approximately $24.5 million to advance its mineral exploration projects. The second tranche, involving shares to a company director, awaits shareholder approval.

Tungsten Mining’s latest Scoping Study confirms Mt Mulgine as a globally significant tungsten and molybdenum project, underpinning a preferred 6 Mtpa development with robust economics and a clear path to production.

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.

ASF Group’s subsidiary has secured AUSTRAC registration as a Digital Currency Exchange, positioning itself for future digital asset opportunities while holding off on active trading.

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.

Platina Resources has identified five promising target zones at its Mt McKenna Gold Project in Western Australia, setting the stage for imminent drilling after securing key approvals and completing detailed surveys.

Accent Resources NL continues its methodical progress on the Magnetite Range Project with ongoing pre-feasibility studies and regulatory groundwork, while awaiting key mining lease approvals for its Norseman Gold Project.

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

SRJ Technologies has made significant strides in its three-year growth plan, securing a $6 million joint venture with a Middle East National Oil Company and raising £1.4 million to fund its regional expansion.

Australian Vanadium Limited advances its vertically integrated vanadium strategy with key regulatory approvals, manufacturing expansions, and a new $10 million loan facility, positioning itself for major energy storage projects.